Mylan, Ranbaxy Can't Halt Pay-For-Delay Suits Pending Appeal
A Pennsylvania federal judge on Thursday refused to pause pay-for-delay litigation against Mylan Inc. and Ranbaxy Laboratories Inc. over Cephalon Inc.'s narcolepsy drug Provigil while the Third Circuit hears the drug...To view the full article, register now.
Already a subscriber? Click here to view full article